Treatment of cancer with irinotecan (CPT-11) and erlotinibDisclosed is a pharmaceutical composition for use in treating cancer, consisting of erlotinib and irinotecan, in a pharmaceutically acceptable carrier.CHEN, JIANPINGHIGGINS, BRIANKOLINSKY, KENNETH...
CPT-11 has also been found to be active in leukemia, lymphoma, SCLC, non-small cell lung cancer, colorectal cancer, ovarian cancer, and cervical cancer. CPT-11 has also demonstrated schedule-dependent antitumor activity and toxicity in preclinical animal models. On this basis, we carried out ...
Intervention code:研究实施地点:Countries of recruitment and research settings:国家:中国省(直辖市):上海市(区县):上海Country:China Province:Shanghai City:Shanghai 单位(医院):复旦大学附属肿瘤医院 单位级别:三甲Institutionhospital:Fudan University Shanghai Cancer Center Level of the institution:Tertiary ...
Small cell lung cancer is extremely sensitive to chemotherapy. Etoposide, a topoisomerase II inhibitor, is one of the most active single agents in chemotherapy, with a 45% response rate as a single agent. Polychemotherapy regimens which include etoposide can be expected to increase responses to 70...
What are phyllodes tumors, and what would be the treatment for a patient with this type of cancer? A 25-year-old woman notes a round, movable, painless lump in her breast. A biopsy would most likely show: A. lobular carcinoma. B. duct...
CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity. CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.Tumori. 1997 Jan-Feb;83(1 Suppl):S85-6. Reviewdoi:10.1177/03008916970831s...
CPT Code G0103 Information CPT Code: G0103 Description: CPT code G0103 refers to a Prostate Specific Antigen (PSA) test which is a screening method for prostate cancer. This is used primarily in a diagnostic laboratory setting. Insurance Guidelines: Medicare covers... Sample appeal letter –...
CPT-11 (Irinotecan) in the treatment of colorectal cancer. Eur J Cancer 1995; 31A: 1283-7.Armand JP, Ducreux M, Mahjoubi M, et al. 1995 CPT-11 (irinotecan) in the treatment of colorectal cancer. Eur J Cancer. 31A:1283–1287.
A North Central Cancer Treatment Group (NCCTG) Study The goals of this study were to determine the response rate (RR) and toxicity of CPT-11 as first-line therapy for gastric and GE junction ADCA, to describe the overall survival (OS) and time to progression (TTP), and to evaluate ...
We evaluated CPT-11 and bevacizumab, which can both cross the blood–brain barrier, as combination therapy to treat HER2–neu-positive breast cancer with brain metastases.关键词: BREAST cancer ONCOLOGIC surgery BREAST cancer treatment CANCER radiotherapy BRAIN metastasis DOI: 10.1093/omcr/omv010 ...